Overcoming the toxicity and dedifferentiation barriers of cellular partial reprogramming to safely accelerate human longevity.
Explore The CircuitOur proprietary biosensor actively senses epigenetic age at the single-cell level. By anchoring at verified pan-tissue age markers, the system detects rejuvenated states to seamlessly halt reprogramming, effectively bypassing traditional clinical barriers.
We are currently seeking strategic partners and angel investments to bypass the traditional academic pipeline and accelerate this technology to the clinic.
Direct Contact:
founder@epiguard.bio